New Hampshire Oncology - Hematology, PA

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC	non-small cell lung carcinoma	Active, not recruiting	Phase 2	2026-10-01		NCT05798663

Clinical trials